Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Issue: Jul/Aug 2022 - Volume 26, Number 4
View All Articles in Issue
Page(s): 293-296
Download in electronic PDF format for $65
Abstract: Medications on the market for the treatment of arthritis are more commonly appropriate for adult arthritic patients. However, for patients with juvenile arthritis, a compounding pharmacist can prepare specialized medications for those patients who are in need of a specific dosage, or for those patients who require a different dosage form. Additionally, more than one active ingredient can be combined in pharmacy compounding to meet a specific patient’s needs. Compounded topical/transdermal preparations can provide customized medication options, which may not be commercially available, for pediatric patients with juvenile arthritis.
Related Keywords: Amy Harrington, LaVonn Williams, juvenile arthritis, topical preparations, transdermal administration, pediatric rheumatic disease, autoimmune disorders, autoinflammatory diseases, inflammation, anti-inflammatory agents, nonsteroidal anti-inflammatory drugs, NSAIDs, corticosteroids, disease-modifying antirheumatic drugs, DMARDs, biologic DMARDS, tumor necrosis factor inhibitors, medication adherence
Related Categories: PAIN MANAGEMENT, PEDIATRICS, ALLERGY/IMMUNOLOGY/INFLAMMATION, MUSCULOSKELETAL DISORDERS